We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Leading Chikungunya Vaccine in Phase 2 Clinical Trial

News   Aug 26, 2016

 
Leading Chikungunya Vaccine in Phase 2 Clinical Trial
 
 
Advertisement
 

RELATED ARTICLES

Phase 1 Clinical Trial of University of Queensland COVID-19 Vaccine Begins

News

The first participants were enrolled into a Phase 1 clinical trial of the University of Queensland’s (UQ) COVID-19 vaccine candidate on July 13.

READ MORE

Hydroxychloroquine Reduces Incidence of Heartbeat Condition in Newborns

News

Researchers show that giving the antimalarial drug hydroxychloroquine to pregnant women who previously had a child affected by congenital heart block reduced the likelihood that the condition recurred in a subsequent pregnancy by 50%.

READ MORE

SARS-CoV-2 Immunity Rapidly Declines Within Months of Infection

News

A recent preprint study indicates that there is a rapid decline in the levels of SARS-CoV-2 neutralizing antibodies during the weeks following initial infection. This raises questions over the potential for re-infection, the effectiveness that may be expected from vaccination and the viable window for antibody testing in disease surveillance.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE